Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients

Rheumatology (Oxford). 1999 Aug;38(8):714-20. doi: 10.1093/rheumatology/38.8.714.

Abstract

Objective: To investigate the effect of the synovial fluid from knee joints of rheumatoid arthritis (RA) patients with different severities of joint destruction on osteoclastogenesis and bone resorption.

Methods: Synovial fluid was harvested from the knee joints of 59 RA patients and 37 ostcoarthritis (OA) patients. RA patients with Larsen's knee grade 1-3 were classified as mild RA (n = 30) and those with grade 4 or 5 as severe RA (n = 29). Cytokine concentrations in synovial fluid were measured by ELISA. Osteoclastogenesis was measured by tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cell (MNC) formation in a co-culture of mouse osteoblastic cells and bone marrow cells, and bone resorption by 45Ca release from pre-labelled cultured neonatal mouse calvariae.

Results: The synovial fluid of severe RA patients significantly stimulated TRAP-positive MNC formation and 45Ca release compared to those of mild RA and OA patients. Among the bone-resorptive cytokines fibroblast growth factor-2 (FGF-2), tumour necrosis factor alpha (TNF-alpha), interleukin-1alpha (IL-1alpha), IL-6 and soluble IL-6 receptor (sIL-6R), only FGF-2 concentration in the synovial fluid was positively correlated to Larsen's grade, and severe RA patients showed significantly higher FGF-2 concentrations than mild RA patients. Osteoclastogenesis in a co-culture system which was stimulated by the synovial fluid of severe RA patients was significantly inhibited by a neutralizing antibody against FGF-2 and this inhibition was stronger than antibodies against other cytokines.

Conclusion: The increase in endogenous FGF-2 levels in the synovial fluid of RA patients may play a role in the joint destruction by inducing osteoclastogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / pathology
  • Arthritis, Rheumatoid / physiopathology*
  • Bone Resorption*
  • Calcium / metabolism
  • Cell Differentiation / drug effects
  • Coculture Techniques
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytokines / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblast Growth Factor 2 / physiology*
  • Humans
  • Male
  • Mice
  • Middle Aged
  • Nitrobenzenes / pharmacology
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • Osteoarthritis / physiopathology
  • Osteoclasts / cytology
  • Osteoclasts / drug effects
  • Sulfonamides / pharmacology
  • Synovial Fluid / metabolism

Substances

  • Cyclooxygenase Inhibitors
  • Cytokines
  • Nitrobenzenes
  • Sulfonamides
  • Fibroblast Growth Factor 2
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Calcium